A detailed history of Lazard Asset Management LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Lazard Asset Management LLC holds 16 shares of TECH stock, worth $1,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16
Previous 16 -0.0%
Holding current value
$1,136
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$62.12 - $84.15 $496 - $673
8 Added 100.0%
16 $1,000
Q4 2023

Feb 14, 2024

SELL
$52.83 - $78.22 $9,509 - $14,079
-180 Reduced 95.74%
8 $0
Q3 2023

Nov 14, 2023

SELL
$67.52 - $89.42 $8,034 - $10,640
-119 Reduced 38.76%
188 $12,000
Q2 2023

Aug 14, 2023

SELL
$73.76 - $85.98 $44,698 - $52,103
-606 Reduced 66.37%
307 $25,000
Q1 2023

May 15, 2023

BUY
$71.62 - $86.62 $25,783 - $31,183
360 Added 65.1%
913 $66,000
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $36,462 - $159,235
452 Added 447.52%
553 $45,000
Q3 2022

Nov 14, 2022

SELL
$282.54 - $391.85 $326,616 - $452,978
-1,156 Reduced 91.96%
101 $28,000
Q2 2022

Aug 09, 2022

BUY
$322.67 - $449.65 $329,768 - $459,542
1,022 Added 434.89%
1,257 $435,000
Q1 2022

May 13, 2022

SELL
$353.85 - $487.79 $2.02 Million - $2.79 Million
-5,721 Reduced 96.05%
235 $101,000
Q4 2021

Feb 09, 2022

SELL
$456.15 - $525.06 $3.02 Million - $3.47 Million
-6,615 Reduced 52.62%
5,956 $3.08 Million
Q3 2021

Nov 15, 2021

SELL
$444.87 - $538.88 $604,133 - $731,799
-1,358 Reduced 9.75%
12,571 $6.09 Million
Q2 2021

Aug 12, 2021

BUY
$387.35 - $450.26 $4.05 Million - $4.71 Million
10,462 Added 301.76%
13,929 $6.27 Million
Q1 2021

May 14, 2021

BUY
$314.62 - $411.0 $1.09 Million - $1.42 Million
3,467 New
3,467 $1.32 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.79B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.